Highlights
ASX: GTG       GENETIC TECHNOLOGIES LIMITED
Last Price Today's Change   Day's Range   Trading Volume
0.004   0.00 (0.00%)  0.004 - 0.004  409,238

Overview

 
Avg Volume (4 weeks):5,418,859
4 Weeks Range:0.004 - 0.006
4 Weeks Price Volatility (%):
0.00%
52 Weeks Range:0.004 - 0.012
52 Weeks Price Volatility (%):
0.00%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Genetic Technologies Limited is a molecular diagnostics company. The Company is engaged in the provision of molecular risk assessment for cancer. The Company offers predictive testing and assessment tools for physicians to manage women's health. The Company's lead product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The Company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/gynecologists (OBGYNs) and breast cancer risk assessment specialists, such as breast surgeons. The Company operates in Australia, the United States and Switzerland. The Company's subsidiaries include Genetic Technologies Corporation Pty. Ltd. and Phenogen Sciences Inc. Genetic Technologies Corporation Pty. Ltd. is engaged in genetic testing. The Company has launched the BREVAGen test across the United States through Phenogen Sciences Inc.

  Be the first to like this.
 


 

385  659  901  2415 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 IMU 0.053+0.008 
 NHL 0.071-0.004 
 TTB 0.10+0.022 
 ECT 0.0010.00 
 SEA 0.1650.00 
 ISX 1.070.00 
 HMD 0.27+0.055 
 CIO 0.0040.00 
 VEC 0.0120.00 
 AZM 0.0320.00 
Partners & Brokers